The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 07, 2021
Filed:
Feb. 12, 2020
Applicant:
Unicyte Ev Ag, Oberdorf, CH;
Inventors:
Maria Felice Brizzi, Turin, IT;
Giovanni Camussi, Turin, IT;
Assignee:
UNICYTE EV AG, Oberdorf, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/04 (2006.01); A61K 35/28 (2015.01); A61K 35/407 (2015.01); C12N 15/113 (2010.01); A61K 31/713 (2006.01); A61P 3/10 (2006.01); A61K 9/127 (2006.01); A61K 31/7105 (2006.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 9/127 (2013.01); A61K 31/713 (2013.01); A61K 31/7105 (2013.01); A61K 35/407 (2013.01); A61K 48/00 (2013.01); A61P 3/10 (2018.01); C12N 15/113 (2013.01); C12N 2310/141 (2013.01); C12N 2320/30 (2013.01);
Abstract
The invention relates to a new therapeutic application of pharmaceutically acceptable carriers containing miR222. In particular, the invention relates to the use of extracellular vesicles (EVs) which contain the microRNA miR222, in the treatment of fibrotic disease caused by hyperglycaemia, such as diabetic nephropathy and/or renal fibrosis.